Received Jun 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945663 | IM / RA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4a4bm | IM / RA |
Patient had a cardiac arrest during his routine daily walk. CPR was conducted, and patient is currently recovering in the hospital.
HTN, BPH, Hyperlipidemia, History of open-heart surgery,
clonidine 0.1 mg, olmesartin-hctz 20-12.5 mg, tadalafil 5mg, rosuvastatin 20mg, finasteride 5mg, carvedilol 6.25mg, tamsulosin 0.4mg
NKDA